Bibliography for Item 6 in BGP

Used Resources

• Merck, "Merck Annual Report: 2000," 2000, Last Accessed April 6 2009, http://www.anrpt2000.com/
• Wikipedia, Amgen, http://en.wikipedia.org/wiki/Amgen
• Wikipedia, Genentech, http://en.wikipedia.org/wiki/Genentech
• Wikipedia, Genzyme, http://en.wikipedia.org/wiki/Genzyme
• Wikipedia, Gilead_Sciences, http://en.wikipedia.org/wiki/Gilead_Sciences
• Wikipedia, Biogen_Idec, http://en.wikipedia.org/wiki/Biogen_Idec
• Wikipeida, Cephalon, http://en.wikipedia.org/wiki/Cephalon
• Wikipeida, MedImmune http://en.wikipedia.org/wiki/MedImmune
• Wikipedia, Celgene, http://en.wikipedia.org/wiki/Celgene
• Wikipedia, ImClone_Systems, http://en.wikipedia.org/wiki/ImClone_Systems
• Wikipedia, List of Biotechnology Companies, http://en.wikipedia.org/wiki/List_of_biotechnology_companies
• Bernheim, Malkie and Jessica Disch "Elsevier Partners With Communispace to Launch Global Online Community", Fox Business, Wednesday, March 25, 2009. Last Accessed: March 29, 2009 Available at: http://www.foxbusiness.com/story/markets/industries/media/elsevier-partners-communispace-launch-global-online-community/
• 2collab, Elsevier B.V., 2009. Available at: http://www.2collab.com/
• "What is 2collab?", Elsevier B.V., 2009. Available at: http://www.2collab.com/about
• "FAQ", Elsevier B.V., 2009. Available at: http://www.2collab.com/faq
• Smith, Laura, "Elsevier Dips Toe in Web 2.0 Water," Information World Review, November 2007
• "Elsevier Sponsors a More Open Access Journal Model", Information World Review, July/August 2006
• Albanese, Andrew, "Elsevier Tries Open Access Option," Library Journal, July, 2006. pp. 22
• "PMC Back Issue Digitization Project", PubMed Central, February 2, 2008. Last Accessed MArch 29 2009. Available at: http://www.pubmedcentral.nih.gov/about/scanning.html
• "Facts and Figures", Verlagsgruppe Georg von Holtzbrinck, Last Accessed March 29 2009. Available at: http://www.holtzbrinck.com/artikel/778437&s=en
• "Nature Biotechnology", Wikipedia, Last Accessed March 29 2009. Available at: http://en.wikipedia.org/wiki/Nature_Biotechnology.
• "Policy statement: Nature Publishing Group to publish genomes using Creative Commons licence," Nature Publishing Group, December 2007. Available at: http://www.nature.com/press_releases/policystatement_pr.pdf
• Baynes, Grace, "InnoCentive and Nature Publishing Group announce partnership to facilitate open innovation," Nature Publishing Group, March 20 2009. Last Accessed March 29 2009. Available at: http://www.nature.com/press_releases/innocentive.html
• Questi, Terra "Scientists Get a 2nd Life," ScienceNews, March 24 2008. Last Accessed March 29 2009. Available at: http://www.sciencenews.org/view/feature/id/31953/title/Scientists_Get_a_2nd_Life.
• Smith, Laura, "Developing nations get free journal access from Nature" Information World Review, April 23 2008, Last Accessed March 29 2009. Available at: http://www.iwr.co.uk/information-world-review/news/2214951/developing-nations-free-journal
• "Connotea," Nature Publishing Group, 2009. Last Accessed March 29 2009. Available at: http://www.connotea.org/
• Thomas, Kim, "Nature injects Sermo buttons," Information World Review, February 4 2008, Last accessed: March 29 2009. Available at: http://www.iwr.co.uk/information-world-review/news/2208994/nature-injects-sermo-buttons-3779408
• Musgrove, Mike, "Into Facebook and Old Friends" Washington Post, September 30 2007, Last accessed March 29 2009. Available at: http://www.iwr.co.uk/information-world-review/news/2208994/nature-injects-sermo-buttons-3779408
• "Foo's paradise" Nature Publishing Group, August 23 2006, Last accessed March 29 2009, Available at: http://www.nature.com/nature/journal/v442/n7105/full/442848a.html
• "Online video streaming archive," Nature Publishing Group, Last accessed MArch 29 2009, Available at: http://www.nature.com/nature/videoarchive/index.html
• Suber, Peter, "Springer on the block," Open Access News March 27 2009, Last accessed March 29 2009, Available at: http://www.nature.com/nature/videoarchive/index.html
• "Cutting-Edge Resources," Springer, Last accessed March 29 2009, Available at: http://www.springer.com/references?SGWID=0-151102-12-358799-0
• "Welcome to SpringerLink!", Springer, Last accessed March 29 2009, Available at: http://www.springerlink.com/home/main.mpx
• "Springer Open Choice", Springer, Last accessed March 29 2009, Available at: http://www.springer.com/open+choice?SGWID=0-40359-0-0-0
• Albanese, Andrew, "Springer Acquires BioMed Central", Library Journal, November 1 2008, Last accessed March 29 2009, Available at: http://www.libraryjournal.com/index.asp?layout=talkbackCommentsFull&talk_back_header_id=6562538&articleid=CA6606529
• Suber, Peter, "Springer's first US deal in which subscriptions cover publication fees for affiliated authors," Open Access News, January 21 2009, Last accessed March 29 2009, http://www.earlham.edu/~peters/fos/2009/01/springer-first-us-deal-in-which.html
• "Springer and Open Access," Springer, November 7 2008, Last accessed March 29 2009, Available at: http://www.springer-sbm.com/index.php?id=13036&L=0
• "Springer and other publishers extend commitment to developing world", July 10 2007, Last accessed March 29 2009, Available at: http://www.springer-sbm.com/index.php?id=291&backPID=11954&L=0&tx_tnc_news=3499&cHash=604b37401f
• "Springer Statement on the Debate on the NIH’s Public Access Policy," September 14 2007, Last accessed March 29 2009, Available at: http://www.springer-sbm.com/index.php?id=291&backPID=11954&L=0&tx_tnc_news=3665&cHash=0c955b5ca7
• Suber, Peter, "Springer buys BioMed Central," Open Access News, October 7 2008, Last accessed March 29 2009, Available at: http://www.springer-sbm.com/index.php?id=291&backPID=11954&L=0&tx_tnc_news=3665&cHash=0c955b5ca7
• "BioMed Central," BioMed Central, Last accessed March 29 2009, Available at: http://www.biomedcentral.com/
• "BioMed Central Databases," BioMed Central, Last accessed March 29 2009, Available at: http://databases.biomedcentral.com/

Last accessed March 29 2009, Available at: http://databases.biomedcentral.com/

• "Starting an independent, open access journal," BioMed Central, Last accessed March 29 2009, Available at: http://www.biomedcentral.com/independent/starting

• Amgen, "Acquisition History", 200. Available at: http://www.amgen.com/about/acquisitions.html
• Pharmaceutical Business Review, "Amgen Inc." http://www.pharmaceutical-business-review.com/companyprofile.asp?guid=8632C7AC-1633-4198-8551-BB79570C668D
• Funding Universe, "Amgen, Inc.", http://www.fundinguniverse.com/company-histories/Amgen-Inc-Company-History.html
• Zhang, Lei, et. al., "Constructing Stack Tables with Magic %GluePlus (Another User-Defined Macro for Creating Stack Tables)" Scientific Commons, http://en.scientificcommons.org/40666678
• The Free Library, "Axys - Amgen Collaboration Determines the X-Ray Crystal Structure of Human Erythropoietin-Receptor Complex." http://www.thefreelibrary.com/Axys+-+Amgen+Collaboration+Determines+the+X-Ray+Crystal+Structure+of...-a053047665
• Brigham and Women's Hospital, "Press Release - Oct 24, 2006," October 24 2006, http://www.brighamandwomens.org/Pressreleases/PressRelease.aspx?PageID=201
• Amgen, "Amgen's Policy on Sharing Our Clinical Trial Results" May 31, 2007, http://switch.atdmt.com/action/deicrm_N53107Policy_6
• Scientific Commons, "Genentech Inc," http://en.scientificcommons.org/genentech_inc
• Atkins, Simon, "Apple Releases Apple/Genentech BLAST, Significantly Accelerating Protein and DNA Searches For The Biomedical Community" Apple Inc., February 7 2002, http://www.apple.com/ca/press/2002/02/genentech.html
• Scheller, Richard, "Our Research Vision: Home," Genentech, http://www.gene.com/gene/research/researchvision.html
• Wikipedia, "Hoffman-La Rouche," http://en.wikipedia.org/wiki/Hoffmann-La_Roche
• McCracken, Joe, "A Novel Approach Towards Sales and Research," e-corner, November 30 2006 http://ecorner.stanford.edu/authorMaterialInfo.html?mid=1614
• McCracken, Joe, "Genentech's Business Model," e-corner, November 30 2006 http://ecorner.stanford.edu/authorMaterialInfo.html?mid=1613
• Genentech, "Immunology Clinical Fellowship" http://www.gene.com/gene/pipeline/fellowship/
• Genentech, "Research Contracts and Reagents Program," http://www.gene.com/gene/reagents-program/reagents-program.jsp
• Genentech, "Press Releases: Thursday, Dec 20, 2007" December 20 2007 http://www.gene.com/gene/news/press-releases/press_statements/ps_122007.html
• Genentech, "Scientific Resource Board," http://www.gene.com/gene/research/resourceboard/
• Ramsey, Doug, "UC San Diego, Genentech scientists develop potentially disruptive antibody sequencing technology," UC Newsroom, December 18, 2008, http://www.universityofcalifornia.edu/news/article/19205
• Genentech Foundation, "Focus Areas," 2006. http://www.genentechfoundation.com/about_focus.html
• Ravven, Wallace, "New UCSF Mission Bay campus: country’s largest biomedical university expansion," University of California, San Francisco, July 22, 2003, http://news.ucsf.edu/releases/new-ucsf-mission-bay-campus-countrys-largest-biomedical-university-expansio/
• Science Blog, "Rockefeller University researchers discover immune-cell mechanism that boosts therapeutic antibody potency," 2000, http://www.scienceblog.com/community/older/2000/D/200003674.html
• Genzyme, "Fabry Community" http://www.fabrycommunity.com/global/fc_p_hp_homepage.asp
• Genzyme, "Genzyme Websites" http://www.genzyme.com/home/global_sites.asp
• Genzyme, "Gaucher Registry," https://www.lsdregistry.net/gaucherregistry/
• Genzyme, "Clinical Research" http://www.genzymeclinicalresearch.com/
• Genzyme, "Our Research: Patents and Literature" http://www.genzyme.com/research/patents/pat_home.asp
• Genzyme, "Community: Grant Applications," http://www.genzyme.com/commitment/community/grant_application.asp
• Genzyme, "Genzyme to Build New R&D Center in Beijing," April 22, 2008, http://www.genzyme.com/corp/media/GENZ%20PR-042208.asp
• Gilead Sciences, "Corporate Fact Sheet," http://www.gilead.com/corporate_fact_sheet
• Gilead Sciences, "Gilead HIV Clinical Cooperation Grant," http://www.gilead-grant.de/disclaimer.html
• Tucker, Valerie, "Gilead Sciences and Gladstone to Collaborate on HIV Targets" University of California, San Francisco, January 10 2008, http://today.ucsf.edu/stories/gilead-sciences-and-gladstone-to-collaborate-on-hiv-targets/
• Gilead Sciences, "Access in the Developing World," http://www.gilead.com/access_developing_world
• Gilead Sciences, "Gilead Foundation," http://www.gilead.com/Gilead_Foundation
• Biogen Idec, "Community Relations," http://www.biogenidec.com/site/community-relations.html
• Fox Business, "Biogen Idec to Present at the 4th Annual Citi Biotech Day," March 30, 2009, http://www.foxbusiness.com/story/markets/industries/health-care/biogen-idec-present-th-annual-citi-biotech-day/
• Biogen Idec, "Biogen Idec Innovation Incubator (bi3)" http://www.biogenidec.com/site/biogen-idec-innovation-incubator.html
• Cephalon, "Our Story" http://www.cephalon.com/about-us/our-story/
• Bennett, Johanna, "It's Wake-Up Time for a Drug Maker's Shares," Barron's, http://online.barrons.com/article/SB123922500386002435.html
• Kennedy, Val Brickates, "Cephalon To Apply For FDA Approval For Nuvigil For Jet Lag," Fox News, April 6, 2009, http://www.foxbusiness.com/story/markets/industries/health-care/cephalon-apply-fda-approval-nuvigil-jet-lag/
• Medical News Today, "Cephalon Announces Positive Results From A Phase Two Study Of NUVIGIL In Bipolar Depression," March 18, 2009, http://www.medicalnewstoday.com/articles/142610.php
• Feuerstein, Adam, "What's on Lilly's Prescription Pad?" TheStreet.com, http://www.thestreet.com/story/10479877/1/whats-on-lillys-prescription-pad.html?puc=_tscrss
• Steven, Brendan, "2 Potential Pharma M&A Targets: Cephalon and Genzyme," Seeking Alpha, March 23, 2009, http://seekingalpha.com/article/127323-2-potential-pharma-m-a-targets-cephalon-and-genzyme?source=feed
• Domain-B, "Cephalon opens bid for Aussie bio-technology firm Arana," February 29 2009 http://www.domainb.com/industry/pharma/20090228_cephalon.html
• Cephalon, "Research Partnerships," http://www.cephalon.com/partners/research-partnerships/
• Cephalon, "Going Further in Research," https://cns.cephaloniss.com/
• Cephalon, "Business Collaboration," http://www.cephalon.com/partners/business-collaboration/
• Cephalon, "Our Science," http://www.cephalon.com/our-science/
• Cephalon, "Corporate Giving," http://www.cephalon.com/corporate-giving/
• B-Net, "Ambit Biosciences Announces Discovery and Development Collaboration with Cephalon, Inc. Focused on Kinase Inhibitors," http://findarticles.com/p/articles/mi_m0EIN/is_2006_Nov_6/ai_n16820350/?tag=content-inner;col1
• PR Newswire, "Abbott Laboratories and Cephalon Sign Collaboration Agreement for Gabitril(R) (Tiagabine Hydrochloride) in the United States" June 10 1999, http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/06-10-1999/0000960938&EDATE=
• MedImmune, "Company Overview," http://www.medimmune.com/about/index.asp
• MedImmune, "Drug Development," http://www.medimmune.com/pipeline/technology/index.asp
• Pollack, Andrew, "Five Days; Biotech Deal," New York Times, Apri 28 2007, http://query.nytimes.com/gst/fullpage.html?res=9505E1D7123EF93BA15757C0A9619C8B63
• Associated Press, "Panel Endorses Flu Vaccine In a Spray for Young Children," October 25 2007, http://query.nytimes.com/gst/fullpage.html?res=9907EEDF1230F936A15753C1A9619C8B63
• Murret, Patricia, "Big Gaithersburg biotech gets a boost," Gazette.net, December 24 2008, http://www.gazette.net/stories/12242008/poolnew194630_32483.shtml
• MedImmune, "MedImmune Announces Winners of Third Annual Research Abstract Competition" November 17 2008, http://www.medimmune.com/press/fullstory.asp?reqid=1227384&yr=2008
• MedImmune, "MedImmune Grants Five New Fellowships to Help Expand Premature Infant Follow-Up Care Research," October 13 2008, http://www.medimmune.com/press/fullstory.asp?reqid=1208757&yr=2008
• MedImmune, " MedImmune Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas," January 7 2008, http://www.medimmune.com/press/fullstory.asp?reqid=1092864&yr=2008
• MedImmune, "R&D Collaborations," http://www.medimmune.com/pipeline/collaborations.asp
• MedImmune, "Strategic Alliances," http://www.medimmune.com/about/company/alliances.asp
• Celgene, "Products and Services," http://www.celgene.com/products/revlimid-thamolid-home.aspx
• Celgene, "History," http://www.celgene.com/about-celgene/biopharmaceutical-company-about.aspx
• Seeking Alpha, "Celgene Breaking New Lows, But Hopefully Not Much Lower," http://seekingalpha.com/article/129142-celgene-breaking-new-lows-but-hopefully-not-much-lower?source=feed
• Weill Cornell Medical College, "Celgene Corporation and Weill Cornell Initiate Research Program To Evaluate the Molecular Mechanism by Which Thalidomide and IMiDs Modulate COX-2," November 20, 2001, http://news.med.cornell.edu/wcmc/wcmc_2001/11_20_01.shtml
• All Business, "Pharmacopeia achieves research milestone in Celgene collaboration." July 1 2003, http://www.allbusiness.com/technology/619727-1.html
• Laboratory Talk, "Celgene and Galapagos in target collaboration" November 23 2004, http://www.laboratorytalk.com/news/gal/gal100.html
• Access My Library "AxCell Biosciences establishes research collaboration with Celgene Corp." January 21 2003, http://www.accessmylibrary.com/coms2/summary_0286-22393688_ITM
• LinkedIn "Abraxis BioSciences" http://www.linkedin.com/companies/abraxis-bioscience
• Abraxis BioSciences, "About," http://www.abraxisbio.com/about.htm
• Abraxis BioSciences, "Abraxis BioScience Announces Plan to Separate Into Two Independent Public Companies," http://phx.corporate-ir.net/phoenix.zhtml?c=217234&p=irol-newsArticle&ID=1125657&highlight=
• Business Wire, "Abraxis BioScience Announces Plan to Create Abraxis Health, a New Enterprise Focused on Biomarkers and Personalized Medicine," January 29 2009 http://www.businesswire.com/portal/site/home/permalink/?ndmViewId=news_view&newsId=20090120005380&newsLang=en
• Abraxis BioSciences, "Publications," http://www.abraxisbio.com/rnd_publications.htm
• Marcus, Jennifer, "UCLA’s California NanoSystems Institute Partners With Abraxis BioScience to Develop New Nanobiotechnologies," UCLA Newsroom, July 26 2007, http://newsroom.ucla.edu/portal/ucla/UCLA-s-California-NanoSystems-Institute-8110.aspx
• National Comprehensive Cancer Network, "NCCN, Abraxis BioScience and AstraZeneca Announce Collaboration to Conduct Anti-Cancer Drug Studies" October 7 2008, www.nccn.org/about/news/pdf/AO990-266534.pdf (pdf)
• Hoovers, "ImXlone Systems Incorporated," http://www.hoovers.com/imclone/--ID__15468--/free-co-factsheet.xhtml
• FDA, "Erbitux," http://www.fda.gov/CDER/Drug/infopage/erbitux/default.htm
• ImClone Systems, "Company Overview," http://www.imclone.com/overview.php
• ImClone Systems, "Imclone Grant Office," https://www.imclonegrantoffice.com/

Unused Resources

• http://www.frost.com/prod/servlet/cpo/9452439
• http://www.gov.mb.ca/ctt/profiles/biotech/
• http://premium.hoovers.com/subscribe/ind/fr/profile/basic.xhtml?ID=174
• http://www.firstresearch.com/Industry-Research/Biotechnology-Sector.html
• http://www.accessmylibrary.com/comsite5/bin/aml2006_library_auth_tt.pl?item_id=0286-36701821
• interesting small article with sales: http://seekingalpha.com/article/79278-biotech-sector-continues-to-outperform

Navigation

IP Profile of Biggest for-profit companies in BGP
Biotechnology_-_Genomic_and_Proteomics